Morton DL - Search Results

1

Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.

Lee JH, Gulec SA, Kyshtoobayeva A, Sim MS, Morton DL. Lee JH, et al. Among authors: morton dl. Ann Surg Oncol. 2009 Oct;16(10):2834-9. doi: 10.1245/s10434-009-0583-5. Epub 2009 Jul 15. Ann Surg Oncol. 2009. PMID: 19603235 Free PMC article.

2

Age-related lymphatic dysfunction in melanoma patients.

Conway WC, Faries MB, Nicholl MB, Terando AM, Glass EC, Sim M, Morton DL. Conway WC, et al. Among authors: morton dl. Ann Surg Oncol. 2009 Jun;16(6):1548-52. doi: 10.1245/s10434-009-0420-x. Epub 2009 Mar 11. Ann Surg Oncol. 2009. PMID: 19277787 Free PMC article.

3

A 20-year experience of hepatic resection for melanoma: is there an expanding role?

Faries MB, Leung A, Morton DL, Hari D, Lee JH, Sim MS, Bilchik AJ. Faries MB, et al. Among authors: morton dl. J Am Coll Surg. 2014 Jul;219(1):62-8. doi: 10.1016/j.jamcollsurg.2014.04.008. Epub 2014 May 10. J Am Coll Surg. 2014. PMID: 24952441 Free PMC article.

4

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.

Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Lee JH, et al. Among authors: morton dl. J Clin Oncol. 2004 Sep 15;22(18):3677-84. doi: 10.1200/JCO.2004.01.012. J Clin Oncol. 2004. PMID: 15365064

5

Contemporary surgical treatment of advanced-stage melanoma.

Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Essner R, et al. Among authors: morton dl. Arch Surg. 2004 Sep;139(9):961-6; discussion 966-7. doi: 10.1001/archsurg.139.9.961. Arch Surg. 2004. PMID: 15381613

6

Melanoma recurrence patterns after negative sentinel lymphadenectomy.

Zogakis TG, Essner R, Wang HJ, Turner RR, Takasumi YT, Gaffney RL, Lee JH, Morton DL. Zogakis TG, et al. Among authors: morton dl. Arch Surg. 2005 Sep;140(9):865-71; discussion 871-2. doi: 10.1001/archsurg.140.9.865. Arch Surg. 2005. PMID: 16172295

7

CpG island methylator phenotype predicts progression of malignant melanoma.

Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS. Tanemura A, et al. Among authors: morton dl. Clin Cancer Res. 2009 Mar 1;15(5):1801-7. doi: 10.1158/1078-0432.CCR-08-1361. Epub 2009 Feb 17. Clin Cancer Res. 2009. PMID: 19223509 Free PMC article.

8

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.

Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, Hoon DS. Nguyen T, et al. Among authors: morton dl. Epigenetics. 2011 Mar;6(3):388-94. doi: 10.4161/epi.6.3.14056. Epub 2011 Mar 1. Epigenetics. 2011. PMID: 21081840 Free PMC article.

9

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.

Wasif N, Bagaria SP, Ray P, Morton DL. Wasif N, et al. Among authors: morton dl. J Surg Oncol. 2011 Aug 1;104(2):111-5. doi: 10.1002/jso.21903. Epub 2011 Mar 4. J Surg Oncol. 2011. PMID: 21381040 Free PMC article.

10

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.

Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, Li MW, Huang SK, Sim MS, Morton DL, Hoon DS. Hoshimoto S, et al. Among authors: morton dl. J Invest Dermatol. 2012 Jun;132(6):1689-97. doi: 10.1038/jid.2012.36. Epub 2012 Mar 8. J Invest Dermatol. 2012. PMID: 22402438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

686 results

Search Page